Low energy shock wave‐delivered intravesical botulinum neurotoxin‐A potentiates antioxidant genes and inhibits proinflammatory cytokines in rat model of overactive bladder

2020 ◽  
Vol 39 (8) ◽  
pp. 2447-2454
Author(s):  
Mohammed Nageib ◽  
Mohamed H. Zahran ◽  
Ahmed S. El‐Hefnawy ◽  
Nashwa Barakat ◽  
Amira Awadalla ◽  
...  
2019 ◽  
Vol 2019 ◽  
pp. 1-12 ◽  
Author(s):  
Chang-Chun Hsiao ◽  
Wei-Han Huang ◽  
Kuang-Hung Cheng ◽  
Chien-Te Lee

Background. Diabetic nephropathy is the most common cause of end-stage renal disease. Traditional therapy for diabetic nephropathy has focused on supportive treatment, and there is no significant effective therapy. We investigated the effect of low-energy extracorporeal shock wave therapy on a diabetic nephropathy rat model. Methods. Streptozotocin-induced diabetic nephropathy rats were treated with six sessions of low-energy extracorporeal shock wave therapy (weekly for six consecutive weeks) or left untreated. We assessed urinary creatinine and albumin, glomerular volume, renal fibrosis, podocyte number, renal inflammation, oxidative stress, and tissue repair markers (SDF-1 and VEGF) six weeks after the completion of treatment. Results. The six-week low-energy extracorporeal shock wave therapy regimen decreased urinary albumin excretion as well as reduced glomerular hypertrophy and renal fibrosis in the rat model of diabetic nephropathy. Moreover, low-energy extracorporeal shock wave therapy increased podocyte number in diabetic nephropathy rats. This was likely primarily attributed to the fact that low-energy extracorporeal shock wave therapy reduced renal inflammation and oxidative stress as well as increased tissue repair potency and cell proliferation. Conclusions. Low-energy extracorporeal shock wave therapy preserved kidney function in diabetic nephropathy. Low-energy extracorporeal shock wave therapy may serve as a novel noninvasive and effective treatment of diabetic nephropathy.


2020 ◽  
Vol 127 (1) ◽  
pp. 80-89 ◽  
Author(s):  
Ahmed Elkashef ◽  
Nashwa Barakat ◽  
Sherry M. Khater ◽  
Amira Awadalla ◽  
Fathallah Belal ◽  
...  

2007 ◽  
Vol 7 ◽  
pp. 808-817
Author(s):  
Shelby N. Morrisroe ◽  
Michael B. Chancellor

Botulinum toxins are well known for their ability to disrupt neurotransmission and cause muscle paralysis. Recently, urologists have discovered their beneficial effects in patients with neurogenic and overactive bladder conditions. This review is intended to provide a quick overview for urologists of the structure, function, and clinical uses of botulinum neurotoxin A in the lower urinary tract.


2011 ◽  
Vol 14 (2) ◽  
pp. 219-228 ◽  
Author(s):  
Salvador Arlandis ◽  
David Castro ◽  
Carlos Errando ◽  
Eldiberto Fernández ◽  
Miguel Jiménez ◽  
...  

2018 ◽  
Vol 15 (2) ◽  
pp. S46
Author(s):  
W.J. Bae ◽  
G.Q. Zhu ◽  
S.W. Choi ◽  
H.C. Jeong ◽  
F. Bashraheel ◽  
...  
Keyword(s):  

2019 ◽  
Vol 44 (5) ◽  
pp. 1262-1268 ◽  
Author(s):  
Zhi Huang ◽  
Yajun Lian ◽  
Yuan Chen ◽  
Shuang Li ◽  
Haifeng Zhang ◽  
...  

2017 ◽  
Vol 6 (S3) ◽  
pp. AB098-AB098
Author(s):  
Woong Jin Bae ◽  
Guan Qun Zhu ◽  
Sae Woong Choi ◽  
Hyun Cheol Jeong ◽  
Fahad Bashraheel ◽  
...  
Keyword(s):  

2018 ◽  
Vol 34 (4) ◽  
pp. 720-727 ◽  
Author(s):  
Keng‐Liang Wu ◽  
Yi‐Chun Chiu ◽  
Chih‐Chien Yao ◽  
Cheng‐En Tsai ◽  
Ming‐Luen Hu ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document